a proposal by the U.S. Drug Enforcement Administration (DEA) passes. For years cannabis is seen as a Schedule I drug, but now it could be moved down to Schedule III. The proposal must be reviewed by the White House Office of Management and Budget. If approved, the DEA would publish the final rule.